Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program Dec 21 • 5 min read Revive Therapeutics Ltd. announced that it has entered into a non-binding letter of intent to acquire the full rights to PharmaTher Inc.’s intellectual property pertaining to psilocybin.
MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand Dec 18 • 4 min read MagicMed Industries Inc. announced the closing of its upsized and oversubscribed previously announced private placement of units of the company for aggregate gross proceeds of approximately $8.1M.
Tryp Therapeutics Completes Initial Public Offering Dec 17 • 3 min read Tryp Therapeutics Inc. announced the successful closing of its previously announced initial public offering.
Numinus Completes First Extraction of its Psilocybe Mushrooms Dec 17 • 5 min read Numinus Wellness Inc. has completed the first legal extraction of Psilocybe mushrooms in Canada by a public company for research and development purposes.
Ehave, Inc. Announces KetaDASH for Ketamine Home Delivery and Purchase of Curedash Assets Dec 16 • 4 min read Ehave, Inc. announced KetaDASH, an Intravenous (IV) based, home delivery platform for patients who have been prescribed Ketamine.